5-(tert-Butyl) 2-ethyl 4-oxo-7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-2,5(6H)-dicarboxylate, 98%, 500mg

2-Chloro-N-isopropyl-5-nitropyrimidin-4-amine, 97.0%, 5g

(1R,1'R)-1,1'-((4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(ethane-1,2-diol), 95.0%, 1g

4-Dimethylamino-N-(5-phenyl-1H-pyrazolo[3,4-c]pyridazin-3-yl)-butyramide, 95.0%, 10mg

3-OXO-3-(PYRIDIN-2-YL)PROPANENITRILE, 98.0%, 250mg

(4R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-ol, 98%, 100mg

4,5,9,10-Tetrabromoisochromeno[6,5,4-def]isochromene-1,3,6,8-tetraone, 95%, 100mg

Medio clostridial reforzado diferencial

Etiquetas WetGrip, 24 x 13 mm, Gesch. para viales de 0,5 ml, 20 unidades

2-(tert-Butyldimethylsilyl)thiazole>97.0%(GC)1g

2-Allyloxyethanol, 95.0%, 25g

4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide, 99.0%, 10g

3-Bromo-4-cyanopyridine, 95.0%, 10g